Quanta BioSciences

NEW YORK (GenomeWeb) ― Tracking immunity and virus shedding after oral polio vaccination usually requires culture of poliovirus from stool samples.

NEW YORK (GenomeWeb) – An international team of academic and industry researchers this week published the results of a comparison of commercially available platforms for microRNA expression analysis, finding that each has its own strengths and shortcomings that should be considered before selecti

NEW YORK (GenomeWeb News) – The US Food and Drug Administration has given 510(k) clearance to the CDC Human Influenza Virus Real-Time RT-PCR Diagnostic Panel.

The University of Washington has been awarded US Patent No. 8,420,325, "Thermostable polymerases having altered fidelity and methods of identifying and using same."
Lawrence Loeb, Leroy Hood, and Motoshi Suzuki are named as inventors.

NEW YORK (GenomeWeb News) – ZyGem today said that it has entered into an agreement with Quanta BioSciences to incorporate its enzymatic RNA-extraction technology into Quanta's quantitative PCR reagent kits.

Corbett Life Science has been awarded US Patent No. 8,124,413, "Thermocycler and sample port."
Keith Stanley and John Corbett are named as inventors on the patent.

Patent watchdog firm Troll Busters has chosen to abandon its lawsuit against more than a dozen life science companies for false patent marking related to various nucleic acid detection, amplification, and cloning technologies, according to recently filed court documents.

A US district court has dismissed a lawsuit filed earlier this year against more than a dozen life science companies alleging that they falsely marked certain nucleic acid detection, amplification, and cloning technologies as being patented after the relevant patents expired.

IDT will produce the assays, which will allow scientists to detect and profile mature miRNA sequences; and will market them through an online catalog directly to customers of Quanta.

IDT will produce the assays and supply them through an online catalog directly to Quanta customers.

Pages

US Attorney General Jeff Sessions is considering using DNA tests to determine relatedness between adult and child migrants, the Daily Caller reports.

Bloomberg reports that Brainstorm Cell Therapeutics plans to offer a treatment it is developing under the "right to try" law for hundreds of thousands of dollars.

In Nature this week: expansion of disease-resistance genes among long-lived oak trees, and more.

In a proof-of-concept study, researchers report being able to determine age from dried bloodstains, Discover's D-brief blog reports.